Change in Perceived Health and Functioning over Time in Patients with Type I Diabetes Mellitus

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2005 Mar 26

PMID 15789936

Citations 10

Authors

Huberta E Hart

William K Redekop

Henk J G Bilo

Marc Berg

Betty Meyboom-de Jong

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to investigate perceived health and functioning (PHF) of patients with type I diabetes mellitus (DMT1) over time and to compare change in perceived PHF with that of a sample of the general population.

Methods: In a Dutch cohort of 234 patients with DMT1 we assessed PHF over time with two generic instruments: RAND-36 and EuroQol. We applied multilevel modelling to estimate change in PHF over the years 1995--2001. We compared change in PHF with change estimated from a comparably aged sample from the general population using a one-sample t-test.

Results: Patients reported a significant decrease in PHF for most RAND-36 subscales. Mean changes in RAND-36 scores ranged from -0.09 (mental health) to -1.18 per year (bodily pain). EQ scores decreased significantly as well. Patients in the cohort had a faster decrease in three RAND-36 subscales and EQ-VAS over time than the estimated decrease in the general population.

Conclusion: This study showed that patients with DMT1 have a faster decrease in PHF over time than comparably aged persons from the general population. The generic instruments used in our study were sensitive enough to measure changes in PHF over time in an adult diabetes population.

Citing Articles

Diabetic Retinopathy Screening in Patients with Diabetes Using a Handheld Fundus Camera: The Experience from the South-Eastern Region in Hungary.

Eszes D, Szabo D, Russell G, Lengyel C, Varkonyi T, Paulik E J Diabetes Res. 2021; 2021:6646645.

PMID: 33628836 PMC: 7884113. DOI: 10.1155/2021/6646645.

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.

Danne T, Cariou B, Buse J, Garg S, Rosenstock J, Banks P Diabetes Care. 2019; 42(5):919-930.

PMID: 30833371 PMC: 6905498. DOI: 10.2337/dc18-2149.

Quantities of comorbidities affects physical, but not mental health related quality of life in type 1 diabetes with confirmed polyneuropathy.

Wegeberg A, Meldgaard T, Hyldahl S, Jakobsen P, Drewes A, Brock B World J Diabetes. 2019; 10(2):87-95.

PMID: 30788046 PMC: 6379728. DOI: 10.4239/wjd.v10.i2.87.

Associations between illness duration and health-related quality of life in specified mental and physical chronic health conditions: results from a population-based survey.

Busija L, Tan J, Sanders K Qual Life Res. 2017; 26(10):2671-2681.

PMID: 28500571 DOI: 10.1007/s11136-017-1592-7.

de Souza A, Felicio J, Koury C, Neto J, Mileo K, Santos F Health Qual Life Outcomes. 2015; 13:204.

PMID: 26703221 PMC: 4690259. DOI: 10.1186/s12955-015-0396-0.

References

Hanestad B . Self-reported quality of life and the effect of different clinical and demographic characteristics in people with type 1 diabetes. Diabetes Res Clin Pract. 1993; 19(2):139-49. DOI: 10.1016/0168-8227(93)90107-g. View

Ware J, Kosinski M . Interpreting SF-36 summary health measures: a response. Qual Life Res. 2002; 10(5):405-13; discussion 415-20. DOI: 10.1023/a:1012588218728. View

REICHARD P, Nilsson B, Rosenqvist U . The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993; 329(5):304-9. DOI: 10.1056/NEJM199307293290502. View

Aaronson N, Muller M, Cohen P, Essink-Bot M, Fekkes M, Sanderman R . Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998; 51(11):1055-68. DOI: 10.1016/s0895-4356(98)00097-3. View

. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia. 1994; 37(3):278-85. DOI: 10.1007/BF00398055. View

Wandell P, Brorsson B, Aberg H . Quality of life among diabetic patients in Swedish primary health care and in the general population: comparison between 1992 and 1995. Qual Life Res. 1999; 7(8):751-60. DOI: 10.1023/a:1008893121086. View

Bott U, Muhlhauser I, Overmann H, Berger M . Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care. 1998; 21(5):757-69. DOI: 10.2337/diacare.21.5.757. View

Crosby R, Kolotkin R, Williams G . Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003; 56(5):395-407. DOI: 10.1016/s0895-4356(03)00044-1. View

Hahl J, Hamalainen H, Sintonen H, Simell T, Arinen S, Simell O . Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Qual Life Res. 2002; 11(5):427-36. DOI: 10.1023/a:1015684100227. View

10.

Kent L, Gill G, Williams G . Mortality and outcome of patients with brittle diabetes and recurrent ketoacidosis. Lancet. 1994; 344(8925):778-81. DOI: 10.1016/s0140-6736(94)92340-x. View

11.

Leventhal E, Prohaska T . Age, symptom interpretation, and health behavior. J Am Geriatr Soc. 1986; 34(3):185-91. View

12.

Atkinson M, Eisenbarth G . Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001; 358(9277):221-9. DOI: 10.1016/S0140-6736(01)05415-0. View

13.

Pouwer F, VAN DER Ploeg H, Ader H, Heine R, Snoek F . The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care. 1999; 22(12):2004-10. DOI: 10.2337/diacare.22.12.2004. View

14.

Reviriego J, Millan M, Millan M . Evaluation of the diabetes quality-of-life questionnaire in a Spanish population. An experience of translation and reliability. Pharmacoeconomics. 1996; 10(6):614-22. DOI: 10.2165/00019053-199610060-00007. View

15.

Woodcock A, Julious S, Kinmonth A, Campbell M . Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res. 2002; 10(8):661-70. DOI: 10.1023/a:1013837709224. View

16.

Wu S, Sainfort F, Tomar R, Tollios J, Fryback D, Klein R . Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life. Diabetes Care. 1998; 21(5):725-31. DOI: 10.2337/diacare.21.5.725. View

17.

Hays R, Sherbourne C, Mazel R . The RAND 36-Item Health Survey 1.0. Health Econ. 1993; 2(3):217-27. DOI: 10.1002/hec.4730020305. View

18.

. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16(3):199-208. DOI: 10.1016/0168-8510(90)90421-9. View

19.

. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care. 1996; 19(3):195-203. DOI: 10.2337/diacare.19.3.195. View

20.

Lloyd C, Orchard T . Physical and psychological well-being in adults with Type 1 diabetes. Diabetes Res Clin Pract. 1999; 44(1):9-19. DOI: 10.1016/s0168-8227(99)00004-2. View